Studying Harms Is Key to Improving Psychedelic-Assisted Therapy-Participants Call for Changes to Research Landscape

This Viewpoint discusses serious adverse events linked to interactions between therapists and patients in trials of psychedelic-assisted therapy.

Automated summary

This Viewpoint examines the potential for serious adverse events resulting from interactions between therapists and patients in trials of psychedelic-assisted therapy.